Literature DB >> 30075407

The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran.

Sharareh Eskandarieh1, Negar Molazadeh1, Abdorreza Naser Moghadasi1, Amir Reza Azimi1, Mohammad Ali Sahraian2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30075407     DOI： 10.1016/j.msard.2018.07.023

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN： 2211-0348            Impact factor:   4.339


× No keyword cloud information.
  6 in total

1.  Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis.

Authors:  Mehdi Rezaee; Mohammad Hossein Morowvat; Maryam Poursadeghfard; Armin Radgoudarzi; Khosro Keshavarz
Journal:  BMC Health Serv Res       Date:  2022-01-28       Impact factor: 2.655

2.  Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.

Authors:  Milad Azami; Mohammad Hossein YektaKooshali; Masoumeh Shohani; Ali Khorshidi; Leily Mahmudi
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

3.  Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.

Authors:  Amir Almasi-Hashiani; Mohammad Ali Sahraian; Sharareh Eskandarieh
Journal:  BMC Neurol       Date:  2020-05-02       Impact factor: 2.474

Review 4.  Multiple sclerosis in Iran: An epidemiological update with focus on air pollution debate.

Authors:  Masoud Amiri
Journal:  J Clin Transl Res       Date:  2021-02-17

5.  Economic burden of multiple sclerosis: a cross-sectional study in Iran.

Authors:  Mehdi Rezaee; Khosro Keshavarz; Sadegh Izadi; Abdosaleh Jafari; Ramin Ravangard
Journal:  Health Econ Rev       Date:  2022-01-03

6.  The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis.

Authors:  Naeim Ehtesham; Maryam Zare Rafie; Meysam Mosallaei
Journal:  BMC Neurol       Date:  2021-06-28       Impact factor: 2.474
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.